Inspections, Compliance, Enforcement, and Criminal Investigations
Wayan Sumartini Saraswati - Close Out Letter 8/25/11
Department of Health and Human Services
|Public Health Service|
Food and Drug Administration
|Center for Tobacco Products|
9200 Corporate Boulevard
Rockville, MD 20850-3229
AUG 25 2011
VIA UPS and Electronic Mail
Dear Sir or Madam:
FDA's Center for Tobacco Products has completed an evaluation of your corrective actions in response our Warning Letter dated July 13, 2011. Based on our evaluation, it appears that you have addressed the violation(s) contained in the Warning Letter by no longer offering for sale your clove cigarettes on http://www.balicigarette.com and http://www.clovecigarettesmarket.com to customers in the United States. Specifically, you deleted the "USA" as a shipping option on both websites.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future.
Ann Simoneau, J.D.
Office of Compliance and Enforcement
Center for Tobacco Products